• We are available for your help 24/7
  • Email: info@isindexing.com, submission@isindexing.com

Paper Details

Covid 19 Associated Mucormycosis: An Epidemic

Covid 19 Associated Mucormycosis: An Epidemic

Kanishk Mehta, Priti Agarwal and Swati Jain

Journal Title:Acta Scientific Otolaryngology

Patients with Coronavirus disease (COVID-19) are commonly treated with broad spectrum antibiotics, glucocorticoids and/or immune modulators. This has led to development/exacerbation of opportunistic fungal infections. Mucormycosis is one such disease that complicates the course of severe COVID-19. Here we present a study of 15 patients and their epidemiology who were diagnosed with Covid19 Associated Mucormycosis (CAM) at our institute - the highest number of cases in literature. Keywords: Mucormycosis; COVID19; Immunosuppression